Risk of post-polypectomy bleeding and thromboembolic events during colonoscopy in patients on continued or interrupted antiplatelet therapy: a pooled analysis

Uninterrupted antiplatelet therapy in elderly patients increases the risk of post-polypectomy bleeding, while the potential elevated risk of thromboembolic events resulting from discontinuation should not be ignored. Especially for high-risk patients, endoscopists must carefully weigh the risk of bleeding and adverse cardiovascular events when deciding whether to interrupt or continue antiplatelet therapy.